Edition:
United States

Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

75.31USD
19 Jun 2018
Change (% chg)

-- (--)
Prev Close
$75.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
95,816
52-wk High
$84.20
52-wk Low
$45.05

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.85 December 20 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 2 2 2
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 51.12 54.00 49.00 68.80
Quarter Ending Sep-18 5 53.57 58.60 47.80 85.50
Year Ending Dec-18 5 212.35 223.30 200.60 276.28
Year Ending Dec-19 5 250.10 273.18 229.90 351.57
Earnings (per share)
Quarter Ending Jun-18 5 0.85 1.16 0.60 1.17
Quarter Ending Sep-18 5 0.96 1.24 0.68 1.65
Year Ending Dec-18 5 3.56 4.30 2.93 4.22
Year Ending Dec-19 5 4.44 4.96 3.71 6.60

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 48.88 46.63 2.25 4.60
Quarter Ending Dec-17 52.91 46.78 6.12 11.58
Quarter Ending Sep-17 51.86 63.02 11.16 21.53
Quarter Ending Jun-17 52.52 50.11 2.41 4.59
Quarter Ending Mar-17 70.37 76.79 6.42 9.12
Earnings (per share)
Quarter Ending Mar-18 0.69 0.53 0.16 22.63
Quarter Ending Dec-17 1.00 1.00 0.00 0.50
Quarter Ending Sep-17 0.80 1.22 0.42 52.98
Quarter Ending Jun-17 0.51 0.28 0.23 45.10
Quarter Ending Mar-17 1.41 1.42 0.00 0.35

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 51.12 51.66 50.61 50.79 68.80
Quarter Ending Sep-18 53.57 52.31 51.29 50.05 85.50
Year Ending Dec-18 212.35 210.86 206.16 201.06 276.28
Year Ending Dec-19 250.10 247.58 247.58 220.98 351.57
Earnings (per share)
Quarter Ending Jun-18 0.85 0.92 0.92 1.00 1.17
Quarter Ending Sep-18 0.96 0.89 0.89 0.96 1.65
Year Ending Dec-18 3.56 3.48 3.48 3.70 4.22
Year Ending Dec-19 4.44 4.14 4.14 4.18 6.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 1 1 1
Quarter Ending Sep-18 0 0 1 0
Year Ending Dec-18 0 1 1 0
Year Ending Dec-19 0 2 0 2
Earnings
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 1 0 1
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 1 1 1 1